NIVESTIM

This brand name is authorized in Austria, Australia, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom

Active ingredients

The drug NIVESTIM contains one active pharmaceutical ingredient (API):

1 Filgrastim UNII PVI5M0M1GW - FILGRASTIM

Filgrastim causes marked increases in peripheral blood neutrophil counts within 24 hours, with minor increases in monocytes. Read about Filgrastim

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L03AA02	Filgrastim	L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 5742F, 5744H, 5829T, 5830W, 6291D, 6292E
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 06439441, 06439458, 06439464, 10541843, 10541866, 10713066, 10713072, 10917320, 11004426, 11004432, 11084514, 11084537, 11141459, 11167683, 11314405, 11320966, 11563479, 11646366, 11649235, 12393157, 12393252, 12566959, 12566965, 13568506, 13881812, 13881829, 14307162, 14310017, 14310023, 15433940, 15433957, 16596822, 16678833
Country: EE	Ravimiamet	Identifier(s): 1482083, 1482094, 1482106, 1482117, 1482128, 1482139, 1482140, 1482151, 1482162, 1726545, 1726556, 1726567
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 110631001, 110631002, 110631004, 110631005, 110631007, 110631008
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 100581, 100614, 100648
Country: FR	Base de données publique des médicaments	Identifier(s): 65387858, 69287684, 69908842
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 174427, 174433, 174438
Country: HK	Department of Health Drug Office	Identifier(s): 60949, 60950, 60951
Country: IE	Health Products Regulatory Authority	Identifier(s): 88537, 88538, 88539
Country: IT	Agenzia del Farmaco	Identifier(s): 040158014, 040158026, 040158038, 040158040, 040158053, 040158065, 040158077, 040158089, 040158091, 040158103, 040158115, 040158127
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1055603, 1055604, 1055605, 1055606, 1055607, 1055608, 1055609, 1055610, 1055611, 1080856, 1080857, 1080858
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 41831, 41858
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 14984, 14985, 14986
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100254826, 100254832, 100254849
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64857001, W64857002, W64857003, W64858001, W64858002, W64858003
Country: SG	Health Sciences Authority	Identifier(s): 14195P, 14196P, 14197P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 13613041H, 13613042H
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699643950036, 8699643950043, 8699643950050, 8699643950067, 8699643950081, 8699643950098